JULIO BELARMINO
BOBES GARCIA
Investigador hasta 2022
![Foto de JULIO BELARMINO](/img/nophoto.png)
![Foto de Universidad del País Vasco/Euskal Herriko Unibertsitatea](/img/noimage_org.png)
Universidad del País Vasco/Euskal Herriko Unibertsitatea
Lejona, EspañaPublicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (28)
2024
-
Clinical predictors and psychosocial risk factors of suicide attempt severity
Spanish Journal of Psychiatry and Mental Health
-
Processing speed mediates the relationship between DDR1 and psychosocial functioning in euthymic patients with bipolar disorder presenting psychotic symptoms
Molecular Psychiatry
2022
-
Combining MRI and clinical data to detect high relapse risk after the first episode of psychosis
Schizophrenia, Vol. 8, Núm. 1
2021
-
Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis
Schizophrenia Research, Vol. 236, pp. 19-28
-
The prevention of relapses in first episodes of schizophrenia: The 2EPs Project, background, rationale and study design
Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 3, pp. 164-176
-
The training of Psychiatry resident: Summary of the discussion table held during the XXII National Congress of Psychiatry. Spain, 2019
Revista de Psiquiatria y Salud Mental
-
The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis
Psychopharmacology, Vol. 238, Núm. 3, pp. 665-676
2020
-
Influence of social cognition as a mediator between cognitive reserve and psychosocial functioning in patients with first episode psychosis
Psychological Medicine, Vol. 50, Núm. 16, pp. 2702-2710
-
Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort
Acta Psychiatrica Scandinavica, Vol. 141, Núm. 6, pp. 541-552
2019
-
CIBERSAM: Ten years of collaborative translational research in mental disorders
Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 1, pp. 1-8
2018
-
Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis
Schizophrenia Research, Vol. 193, pp. 188-196
-
Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?
Psychological Medicine, Vol. 48, Núm. 13, pp. 2247-2256
-
Smoking does not impact social and non-social cognition in patients with first episode psychosis
Schizophrenia Research, Vol. 199, pp. 64-74
2017
-
Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients
European Neuropsychopharmacology, Vol. 27, Núm. 7, pp. 647-656
-
Persistent negative symptoms in first-episode psychosis: Early cognitive and social functioning correlates and differences between early and adult onset
Journal of Clinical Psychiatry, Vol. 78, Núm. 9, pp. 1414-1422
-
The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study
Schizophrenia Research, Vol. 189, pp. 84-90
2016
-
Opposite cannabis-cognition associations in psychotic patients depending on family history
PLoS ONE, Vol. 11, Núm. 8
2015
-
Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis: The PEPsCog Study
Schizophrenia Research, Vol. 164, Núm. 1-3, pp. 65-73
2014
-
Effectiveness of a multi-component smoking cessation support programme (McSCSP) for patients with severe mental disorders: Study design
International Journal of Environmental Research and Public Health, Vol. 11, Núm. 1, pp. 373-389
-
Verbal memory as a mediator in the relationship between subthreshold depressive symptoms and functional outcome in bipolar disorder
Journal of Affective Disorders, Vol. 160, pp. 50-54